XML 41 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
9. Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2018
Stockholders Equity Tables  
Stock option assumptions

The weighted average fair value of stock options granted during the periods and the assumptions used to estimate those values using the Black-Scholes option pricing mode were as follows:  

      Three Months Ended
      March 31,
      2018     2017
Weighted average expected            
     stock price volatility     86.4%     85.0%
Estimated dividend yield     -       -  
Risk-free interest rate     2.7%     2.1%
Expected life of option (in years)     6.3      6.2 
Weighted average grant date            
     fair value per option   $ 1.83    $ 1.86 

 

 

 

Stock option activity

The following table shows the option activity, described above, during the three months ended March 31, 2018 (shares and intrinsic value in thousands):

                  Weighted Average      
            Average     Remaining     Aggregate
            Exercise     Contractual Life     Intrinsic
      Shares     Price     (years)     Value
Options Outstanding at December 31, 2017     1,042    $ 13.80      8.8       
     Granted     336      2.46             
     Exercised     -       -              
     Cancelled     (62)     21.84             
     Expired     -       -              
Options outstanding at March 31, 2018     1,316    $ 10.53      8.9    $
Options vested and expected to vest as of March 31, 2018     850    $ 14.51      8.6    $
Options vested and exercisable as of March 31, 2018     338    $ 24.30      7.8    $ -  

 

 

 

 

 

 

 

Restricted stock activity

The following table shows the Company's non-vested restricted stock activity during the three months ended March 31, 2018 (shares in thousands):

            Weighted Average
            Grant Date Fair
      Shares     Value
Non-vested restricted stock outstanding at December 31, 2017     135    $ 3.17 
     Granted     62      2.46 
     Vested     (1)     2.19 
     Forfeited     -       -  
Non-vested restricted stock outstanding at March 31, 2018     196    $ 2.95